BEDINI, ANDREA
BEDINI, ANDREA
DIPARTIMENTO DI FARMACIA E BIOTECNOLOGIE
Docenti di ruolo di IIa fascia
Quantitative Systems Pharmacology and Biased Agonism at Opioid Receptors: A Potential Avenue for Improved Analgesics
2022 Bedini A.; Cuna E.; Baiula M.; Spampinato S.
Bioluminescence resonance energy transfer (bret) to detect the interactions between kappa opioid receptor and nonvisual arrestins
2021 Bedini A.
Leukocyte Integrin Antagonists as a Novel Option to Treat Dry Age-Related Macular Degeneration
2021 Baiula, Monica; Caligiana, Alberto; Bedini, Andrea; Zhao, Junwei; Santino, Federica; Cirillo, Martina; Gentilucci, Luca; Giacomini, Daria; Spampinato, Santi
Renilla luciferase reporter assay to study 3′-utr-driven posttranscriptional regulation of oprm1
2021 Vincelli G.; Bedini A.
The quest for more effective analgesics with reduced abuse liability and fewer adverse effects: Promises, pitfalls, and future perspectives of biased agonists at opioid receptors
2021 Bedini A.
Functional Selectivity and Antinociceptive Effects of a Novel KOPr Agonist
2020 Bedini A.; Di Cesare Mannelli L.; Micheli L.; Baiula M.; Vaca G.; De Marco R.; Gentilucci L.; Ghelardini C.; Spampinato S.
Reactive oxygen species (ROS) generation is stimulated by opioid receptor activation through phosphorylated c-Jun N-terminal kinase and inhibited by p38 mitogen-activated protein kinase (MAPK) activation
2019 Schattauer S.S.; Bedini A.; Summers F.; Reilly-Treat A.; Andrews M.M.; Land B.B.; Chavkin C.
Constraining Endomorphin-1 by β,α-Hybrid Dipeptide/Heterocycle Scaffolds: Identification of a Novel κ-Opioid Receptor Selective Partial Agonist
2018 De Marco, Rossella; Bedini, Andrea; Spampinato, Santi*; Comellini, Lorenzo; Zhao, Junwei; Artali, Roberto; Gentilucci, Luca
DS-70, a novel and potent α4 integrin antagonist, is an effective treatment for experimental allergic conjunctivitis in guinea pigs
2018 Dattoli, Samantha Deianira; Baiula, Monica; De Marco, Rossella; Bedini, Andrea; Anselmi, Michele; Gentilucci, Luca; Spampinato, Santi*
Innovative opioid peptides and biased agonism: Novel avenues for more effective and safer analgesics to treat chronic pain
2018 Bedini, Andrea*; Spampinato, Santi
Novel Antagonist targeting EphB1 receptor
2018 Gabriela Vaca, Andrea Bedini, Alessandra Tolomelli, Santi Spampinato
Novel Antagonist targeting EphB1 receptor
2018 Gabriela Vaca, Andrea Bedini, Alessandra Tolomelli, Santi Spampinato
Development and characterization of novel EphB1 receptor antagonists.
2017 Gabriela Vaca, Andrea Bedini, Sara Lombardi, Lucia Ferrazzano, Alessandra Tolomelli, Santi Spampinato
Development and characterization of novel EphB1 receptor antagonists.
2017 Gabriela Vaca, Andrea Bedini, Sara Lombardi, Lucia Ferrazzano, Alessandra Tolomelli, Santi Spampinato.
Identification of a new, functional cross-talk between EphB1 receptor and mu opioid receptor
2017 Gabriela Vaca, Andrea Bedini, Sara Lombardi, Santi Spampinato.
Identification of a novel, functional cross-talk between EphB1 receptor and mu opioid receptor
2017 Gabriela Vaca, Andrea Bedini, Sara Lombardi, Santi Spampinato.
Identification of a novel, functional cross-talk between EphB1 receptor and mu opioid receptor.
2017 Gabriela Vaca, Andrea Bedini, Sara Lombardi, Santi Spampinato.
Nociceptin/orphanin FQ antagonizes lipopolysaccharide-stimulated proliferation, migration and inflammatory signaling in human glioblastoma U87 cells
2017 Bedini, Andrea; Baiula, Monica; Vincelli, Gabriele; Formaggio, Francesco; Lombardi, Sara; Caprini, Marco; Spampinato, SANTI MARIO
A Blocking Group Scan Using a Spherical Organometallic Complex Identifies an Unprecedented Binding Mode with Potent Activity In Vitro and In Vivo for the Opioid Peptide Dermorphin
2016 Strack, Martin; Bedini, Andrea; Yip, King T.; Lombardi, Sara; Siegmund, Daniel; Stoll, Raphael; Spampinato, Santi M.; Metzler-Nolte, Nils
Development and characterization of novel EphB1 receptor antagonists
2016 Gabriela Vaca, Andrea Bedini, Sara Lombardi, Lucia Ferrazzano, Alessandra Tolomelli, Santi Spampinato